Cargando…
Applying precision medicine to the active surveillance of prostate cancer
The recent introduction of a variety of molecular tests will potentially reshape the care of patients with prostate cancer. These tests may make more accurate management decisions possible for those patients who have been “overdiagnosed” with biologically indolent disease, which represents an except...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758404/ https://www.ncbi.nlm.nih.gov/pubmed/26149066 http://dx.doi.org/10.1002/cncr.29496 |
_version_ | 1782416603174928384 |
---|---|
author | Reichard, Chad A. Stephenson, Andrew J. Klein, Eric A. |
author_facet | Reichard, Chad A. Stephenson, Andrew J. Klein, Eric A. |
author_sort | Reichard, Chad A. |
collection | PubMed |
description | The recent introduction of a variety of molecular tests will potentially reshape the care of patients with prostate cancer. These tests may make more accurate management decisions possible for those patients who have been “overdiagnosed” with biologically indolent disease, which represents an exceptionally small mortality risk. There is a wide range of possible applications of these tests to different clinical scenarios in patient populations managed with active surveillance. Cancer 2015;121:3435–43. © 2015 American Cancer Society. |
format | Online Article Text |
id | pubmed-4758404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47584042016-02-29 Applying precision medicine to the active surveillance of prostate cancer Reichard, Chad A. Stephenson, Andrew J. Klein, Eric A. Cancer Review Articles The recent introduction of a variety of molecular tests will potentially reshape the care of patients with prostate cancer. These tests may make more accurate management decisions possible for those patients who have been “overdiagnosed” with biologically indolent disease, which represents an exceptionally small mortality risk. There is a wide range of possible applications of these tests to different clinical scenarios in patient populations managed with active surveillance. Cancer 2015;121:3435–43. © 2015 American Cancer Society. John Wiley and Sons Inc. 2015-07-06 2015-10-01 /pmc/articles/PMC4758404/ /pubmed/26149066 http://dx.doi.org/10.1002/cncr.29496 Text en © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Articles Reichard, Chad A. Stephenson, Andrew J. Klein, Eric A. Applying precision medicine to the active surveillance of prostate cancer |
title | Applying precision medicine to the active surveillance of prostate cancer |
title_full | Applying precision medicine to the active surveillance of prostate cancer |
title_fullStr | Applying precision medicine to the active surveillance of prostate cancer |
title_full_unstemmed | Applying precision medicine to the active surveillance of prostate cancer |
title_short | Applying precision medicine to the active surveillance of prostate cancer |
title_sort | applying precision medicine to the active surveillance of prostate cancer |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758404/ https://www.ncbi.nlm.nih.gov/pubmed/26149066 http://dx.doi.org/10.1002/cncr.29496 |
work_keys_str_mv | AT reichardchada applyingprecisionmedicinetotheactivesurveillanceofprostatecancer AT stephensonandrewj applyingprecisionmedicinetotheactivesurveillanceofprostatecancer AT kleinerica applyingprecisionmedicinetotheactivesurveillanceofprostatecancer |